Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Post-operative Crohn's Endoscopic Recurrence Study [Phase 3]
A Phase 3 study examining post-operative endoscopic recurrence in Crohn's disease has completed, sponsored by the University of Melbourne.
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Impact of Physical Exercise on Quality of Life in Patients With Inflammatory Bowel Disease - a Pilot Study. [NA]
A completed pilot study evaluating whether structured physical exercise improves quality of life in patients with inflammatory bowel disease…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera Endoscopy [Phase 4]
A Phase 4 open-label trial evaluated infliximab for induction and maintenance of mucosal healing in small bowel Crohn's disease using wirele…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial) [Phase 3]
Phase 3 COMMIT trial evaluating maintenance therapy with methotrexate and infliximab in Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease [Phase 3]
Phase 3 clinical trial update on a Genzyme-sponsored therapy for moderate to severe Crohn's disease reporting efficacy and safety data; the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease [Phase 1, Phase 2]
Termination of a Phase 1/2 pediatric Crohn's disease trial sponsored by Genzyme; the update discusses the study's safety and efficacy result…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Open-label Trial of Leukine in Active Crohn's Disease [Phase 2]
Open-label Phase 2 trial of Leukine (sargramostim) in active Crohn's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With Sargramostim [Phase 3]
Phase 3 efficacy trial of sargramostim for retreatment of Crohn's disease patients who previously responded to sargramostim has been termina…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease [Phase 3]
Phase 3 trial assessing induction of response/remission and safety in moderate to severe Crohn's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Study in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's Disease [Phase 2]
Phase 2 trial in Crohn's disease patients who are steroid-dependent has completed; the update notes the study status but does not provide re…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Study of Sargramostim in Moderately to Severely Active Crohn's Disease [Phase 2]
A Phase 2 study of sargramostim for moderately to severely active Crohn's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia [NA]
This clinical trial update discusses findings that intravenous iron may induce oxidative stress and inflammation in Crohn's disease patients…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease [Phase 3]
Phase 3 extension study evaluating the safety and efficacy of iron isomaltoside 1000 (Monofer) in subjects with inflammatory bowel disease a…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents [Phase 2]
Phase 2 trial assessing certolizumab pegol for active Crohn's disease in children and adolescents was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Assessment of Capsule Endoscopy Scoring Index (CESI), Harvey-Bradshaw Index (HBI) and Biological Markers in Small Bowel Crohn's Disease (SBCD)
A completed clinical trial assessing the Capsule Endoscopy Scoring Index (CESI), Harvey-Bradshaw Index (HBI), and biological markers for mon…
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease [NA]
Open-label clinical trial update for adults with Pyoderma Gangrenosum and inflammatory bowel disease (Crohn's disease and ulcerative colitis…
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] [Phase 3]
A Phase 3 follow-on safety study for CDP870 in Crohn's disease patients who completed prior trials has completed with results posted in 2013…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Immune Response Regulation and Nutritional Status of the Crohn's Disease Patients. [NA]
A completed clinical trial from the University of Campinas evaluated immune response regulation and nutritional status in Crohn's disease pa…
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo) [Phase 3]
Phase 3 study evaluating CDP870 (certolizumab pegol) versus placebo in Crohn's disease over 26 weeks has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870). [Phase 3]
Phase 3 study assessing CDP870 (certolizumab pegol) in Crohn's disease over 26 weeks, comparing to placebo. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Surveillance of Humira Injection in Korean Patients
Results from a completed clinical trial evaluating Humira (adalimumab) in Korean patients with rheumatoid arthritis, psoriatic arthritis, an…
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease
This clinical trial update reports adherence to the Mesalamine profile in patients with inflammatory bowel disease (ulcerative colitis and C…
-
CLINICAL_TRIALS trial_result · 2013-08-06Clinical Trial Update: Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease [Phase 2]
A Phase 2 trial evaluating interferon beta-1a (Rebif) for Crohn's disease was terminated. The update covers safety and efficacy results from…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease [Phase 2]
Phase 2 study evaluating the safety and efficacy of ustekinumab (CNTO 1275) in Crohn's disease has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Contrast Ultrasound of the Small Intestine in Patients With Crohns Disease
A completed clinical trial evaluated contrast ultrasound of the small intestine in people with Crohn's disease.